MedTrace Logo

A Long-term Safety and Efficacy of EnXtra (E-AG-01) in Healthy Adults

NCT03731286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-03-11

No results posted yet for this study

Summary

The present study has been proposed to investigate the long-term safety and efficacy of EnXtra in healthy adults habituated to caffeine.

Conditions

  • Caffeine Dependence

Interventions

DIETARY_SUPPLEMENT

Alpinia Galanga

2 capsules

DIETARY_SUPPLEMENT

Alpinia Galanga

2 capsules

DIETARY_SUPPLEMENT

Microcellulose crystalline

2 capsules

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-23
Primary Completion
2019-08-30
Completion
2019-12-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03731286 on ClinicalTrials.gov